IBUHEXAL Acute 200 film -coated tablets, 10 pcs

Instructions for use for IBUHEXAL Acute 200 film -coated tablets, 10 pcs

Detailed instructions for IBUHEXAL Acute 200 film -coated tablets, 10 pcs

Field of use

IbuHexal acute 200mg (pack size: 10 pc) is an anti-inflammatory and pain relieving medicine (non-steroidal anti-inflammatory/analgesic).

The medicine is used at

• easy to moderately severe pain such as headache, toothache, menstrual pain, back joke;
• Fever.

IbuHexal acute 200mg (pack size: 10 pc) is also suitable for joint pain and thus in osteoarthritis and arthritis to counteract pain and inflammation. In addition, IbuHexal Akut 200mg (package size: 10 pc) In the event of a flu infection, also as a pain reliever to relieve the fatigue and head, neck, ear or body pain.

Mode of action

IbuHexal acute 200mg (pack size: 10 pc) contains the active ingredient ibuprofen. This is able to prevent the body's production of prostaglandins and thus relieves pain and inflammatory reactions. Ibuprofen therefore has an anti -inflammatory, decongestant and analgesic effect. Ibuprofen can also have a fever -reducing effect on the temperature control center in the brain.

Active ingredients / ingredients / ingredients

IbuHexal acute 200mg (pack size: 10 pc) contains:

Active ingredient:
Ibuprofen
1 film -coated tablet contains 200 mg ibuprofen.

Other ingredients:
Microcrystalline cellulose, croscarmellosis sodium, hypromellosis, macrogol 400, magnesium stearate (ph.eur.), High-disperses silicon dioxide, talcum, titanium dioxide (E 171)

Contradictions

IbuHexal acute 200mg (pack size: 10 pc) must not be taken/applied

• in the case of known hypersensitivity to the active ingredient ibuprofen or one of the other components of the drug;
• if you have reacted in the past with asthma attacks, Crohn's disease, crushing nasal mucus or skin reactions after taking acetylsalicylic acid or other non-steroidal inflammatory inhibitors;
• in the case of unexplained blood formation disorders;
• in the event of existing or repeated stomach/duodenum ulcers (peptic ulcers) or bleeding (at least 2 different episodes of proven ulcers or bleeding);
• in the case of gastrointestinal bleeding or breakthrough (perforation) in the history in connection with previous therapy with non-steroidal anti-rheumatics / anti-inflammatory drugs (NSAID);
• for brain bleeding (cerebrovascular bleeding) or other active bleeding;
• in severe liver or kidney dysfunction;
• with severe heart failure (heart failure);
• in the last third of the pregnancy;
• in children under 20 kg (6 years), since this dose strength is usually not suitable due to the active ingredient content.

Dosage

Application recommendation of IbuHexal Akut 200mg (pack size: 10 pc):

Unless otherwise prescribed by the doctor, the following dosage guidelines apply

Always take the medicine exactly according to instructions. Please ask your doctor or pharmacist if you are not quite sure.

Do not take the preparation without a medical or dental advice for more than 4 days.

Unless otherwise prescribed by the doctor, the usual dose is:

• Body weight (age): approx. 20 kg - 29 kg (6 - 9 years)
  • Single dose in number of tablets: 1 excessive tablet
  • max. Daily dose in the number of tablets: 3 covered tablets
• Body weight (age): 30 kg - 39 kg (10 - 12 years)
  • Single dose in number of tablets: 1 excessive tablet
  • max. Daily dose in the number of tablets: 4 covered tablets
• Body weight (age): > 40 kg (children and adolescents from 12 years and adults)
  • Single dose in number of tablets: 1 - 2 excessive tablets
  • max. Daily dose in the number of tablets: 6 excessive tablets

If you have taken/applied the maximum single dose, wait at least 6 hours until the next intake/application.

Dosage in older people:

• No special dose adjustment is required.

Please speak to your doctor or pharmacist if you have the impression that the effect of the drug is too strong or too weak.

 

• If you have taken/applied a larger amount than you should:
  • Use/apply the medicine according to the instructions of the doctor or the dosage instructions specified here. If you have the feeling that you do not feel sufficient pain relief, then do not increase the dosage independently, but ask your doctor.
  • Central nervous disorders such as headaches, dizziness, dunging and unconsciousness (in children also seizures) as well as abdominal pain, nausea and vomiting can occur as symptoms of overdose. Furthermore, bleeding in the gastrointestinal tract and functional disorders of the liver and kidneys are possible. Furthermore, blood pressure drop, reduced breathing (respiratory depression) and the blue -red color of the skin and mucous membranes (cyanosis) can occur.
  • There is no specific antidote (antidot).
  • If you suspect an overdose with the preparation, please notify your doctor. According to the severity of poisoning, this can decide on the measures necessary.

 

• If you have forgotten the intake/application:
  • If you have forgotten the intake/application, take/use the usual recommended quantity.

Taking

Please take the covered tablets with plenty of liquid (e.g. a glass of water) during or after a meal.

For patients who have a sensitive stomach, it is advisable to take the tablets during meals.

Patient information

Particular caution when taking the drug is required

• Security in the gastrointestinal tract
  • A simultaneous application of the drug with other non-steroidal inflammatory inhibitors, including so-called COX-2 inhibitors (cyclooxygenase-2 inhibitors), should be avoided.
  • Side effects can be reduced by using the lowest effective dose via the shortest period required for symptom control.
  • Older patients:
    • In older patients, side effects occur more frequently after using NSAR, in particular bleeding and breakthroughs in the stomach and intestinal area, which may be life-threatening. Therefore, particularly careful medical monitoring is required in older patients.
  • Bleeding of the gastrointestinal tract, ulcers and breakthroughs (perforations):
    • Bleeding of the gastrointestinal tract, ulcers and perforations, also with a fatal outcome, were reported during treatment with all NSAIDs. They occurred with or without prior warning symptoms or serious events in the gastrointestinal tract in the prehistory at any time of therapy.
  • The risk of the occurrence of gastrointestinal bleeding, ulcers and breakthroughs is higher with increasing NSAR dose, in patients with ulcers in the history, especially with the complications bleeding or breakthrough, and in older patients. These patients should begin treatment with the lowest available dose.
  • For these patients as well as for patients who need accompanying therapy with low-dose acetylsalicylic acid (ASA) or other medicines that can increase the risk of gastrointestinal diseases, a combination therapy with gastric mucosa should protect drugs (e.g. misoprostol or Proton pump inhibitors).
  • If you have a history of side effects on the gastrointestinal tract, especially at older age, you should report any unusual symptoms in the abdomen (especially gastrointestinal bleeding), especially at the beginning of the therapy.
  • Caution is advisable if you get medicines that can increase the risk of ulcers or bleeding, such as: B. Oral corticosteroids, anti-blood clotting drugs such as warfarin, selective serotonin reuptake inhibitors that are used, among other things, to treat depressive moods, or thrombocyte aggregation inhibitors such as ASA.
  • If you have gastrointestinal bleeding or ulcers during treatment with the preparation, the treatment must be discontinued.
  • In patients with a gastrointestinal disease in the prehistory (Colitis Ulzerosa, Crohn's disease), caution should be used because their condition can deteriorate.
• Effects on the cardiovascular system
  • Medicines such as the preparation may be associated with a slightly increased risk of heart attacks ("heart attack") or strokes. Any risk is more likely with high doses and longer treatment. You do not exceed the recommended dose or treatment time (maximum 4 days)!
  • If you have heart problems or a previous stroke or think that you could have a risk for these diseases (e.g. if you have high blood pressure, diabetes or high cholesterol or smokers), you should discuss your treatment with your doctor or pharmacist.
• Skin reactions
  • Under NSAR therapy, serious skin reactions with redness and bladder formation, some with a fatal outcome, were reported (exfediative dermatitis, Stevens-Johnson syndrome and toxic epidermal necrolysis/lyell syndrome). The highest risk of such reactions seems to exist at the beginning of therapy, since these reactions occurred in the majority of cases in the first month of treatment. At the first sign of rashes, mucosal defects or other signs of a hypersensitivity reaction, the medicine should be discontinued and the doctor should be consulted immediately.
  • Using the preparation should be avoided during a chickenpox infection (varicella infection).
• Other information
  • The medicine should only be used with the strict weighing of the benefit-risk ratio:
    • for certain innate blood formation disorders (e.g. acute intermittent porphyria);
    • for certain autoimmune diseases (systemic lupus erythematosus and mixed collagenosis).
  • A particularly careful medical monitoring is required:
    • with limited kidney or liver function;
    • directly after larger surgical interventions;
    • with allergies (e.g. Skin reactions to other medicines, asthma, hay fever), chronic nasal mucus swelling or chronic respiratory diseases narrowing the respiratory tract.
  • Severe acute hypersensitivity reactions (e.g. anaphylactic shock) are very rarely observed. At the first sign of a severe hypersensitivity reaction after taking/administration of the drug, the therapy must be canceled. The symptoms corresponding, medically required measures must be initiated by expert persons.
  • Ibuprofen, the active ingredient of the preparation, can temporarily inhibit the platelet function (thrombocyte aggregation). Patients with blood clotting disorders should therefore be carefully monitored.
  • When the use of ibuprofen-containing medicinal products at the same time, the anticoagulant effect of low-dose acetylsalicylic acid (prevention of the development of blood clots) can be impaired. In this case, you should therefore not use ibuprofen-containing medicines without the express instruction of your doctor.
  • If you are taking on medicinal products at the same time to inhibit blood clotting or to reduce the blood sugar, the blood clotting or blood sugar levels should take place as a precaution.
  • If the preparation is permanently increasing, regular control of the liver values, the kidney function and the blood count is required.
  • When taking the drug before surgical interventions, the doctor or dentist must be questioned or informed.
  • If painkillers are used for a long time, headaches can occur, which may not be treated by increased doses of the drug. Ask your doctor for advice if you often suffer from headache despite taking the preparation!
  • In general, the habitual intake of pain relievers, especially when combining several pain relieving active ingredients, can lead to permanent kidney damage with the risk of kidney failure (analgesic nephropathy).
  • The preparation belongs to a group of medicinal products (non-steroidal anti-rheumatics) that can affect the fertility of women. This effect is reversible after stopping the drug (reversible).

 

• Wateriness and operating machines
  • Since when using the drug in higher dosage, central nervous side effects such as tiredness and dizziness can occur, the reaction capacity can be changed in individual cases and the ability to actively participate in road traffic and to operate machines can be impaired. This applies even more in combination with alcohol. You can then no longer react quickly and specifically to unexpected and sudden events. Do not drive a car or other vehicles in this case!
  • Do not operate any tools or machines! Do not work without a safe grip!

Pregnancy

Pregnancy and breast feeding period
If pregnancy is determined during an application of the drug, the doctor must be notified. You can only use ibuprofen in the first and second thirds of pregnancy after consultation with your doctor. In the last third of pregnancy, the preparation must not be used due to an increased risk of complications for mother and child.

Breastfeeding

• The active ingredient ibuprofen and its dismantling products only pass into breast milk in small quantities. Since disadvantageous consequences for the infant have not yet become known, breastfeeding will generally not be necessary for short -term use. If a longer use or intake of higher doses is prescribed, however, an early wing should be considered.

Hints

Do not take IbuHexal acute 200 without medical or dental advice for more than 4 days.

Keep out of reach of children.

Store with room repair and dry.

Do not apply longer for pain or fever without medical advice than specified in the package insert!

Miscellaneous

Long -term use of painkillers can lead to permanent kidney damage with the risk of kidney failure, especially when several painkillers are taken.
- Inform the doctor immediately for visual disturbances and no longer take the medicine
- The ability to drive of a motor vehicle or to operate machines can be restricted. This is especially true when alcohol is drunk at the same time.
- No special precautionary notices are required when taking ibuprofen as pain relievers.
- If Ibuprofen is taken for a long time, regular control of the liver values, the kidney function and the blood count by the doctor is required.

Terms:
Rheumaanemia

Manufacturer:  Hexal AG, Industriestraße 25, 83607 Holzkirchen